EW - Spark Newswire

1 minute read

FDA Approves Edwards Lifesciences’ Resilia Valve For Mitral Replacement Surgery

Today, 10:52 AM

The FDA has approved Edwards Lifesciences Corp's (NYSE: EW) Mitris Resilia valve, a tissue valve replacement specifically designed for the heart's mitral position.

1 minute read

Analyst Ratings

Analyst Ratings For Edwards Lifesciences

By Benzinga Insights

Today, 10:52 AM

Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:

1 minute read

Bernstein Upgrades Edwards Lifesciences to Outperform, Raises Price Target to $135

By Benzinga Newsdesk

Today, 10:52 AM

Bernstein analyst Lee Hambright upgrades Edwards Lifesciences (NYSE:EW) from Market Perform to Outperform and raises the price target from $132 to $135.

2 minute read

This Foreboding Sign Looms Over Edwards Lifesciences’s Chart

By Benzinga Insights

Today, 10:52 AM

If history is any guide, there may be trouble ahead for shares of Edwards Lifesciences (NYSE:EW). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

9 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For February 2, 2022

By Benzinga Insights

Today, 10:52 AM

ABUS

2 minute read

The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News

By Shanthi Rexaline

Today, 10:52 AM

The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.

ABBV

1 minute read

Analyst Ratings

Where Edwards Lifesciences Stands With Analysts

By Benzinga Insights

Today, 10:52 AM

Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:

1 minute read

SVB Leerink Maintains Outperform on Edwards Lifesciences, Lowers Price Target to $130

By Benzinga Newsdesk

Today, 10:52 AM

SVB Leerink analyst Danielle Antalffy maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $132 to $130.

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 10:52 AM

Gainers Reneo Pharmaceuticals (NASDAQ:RPHM) shares increased by 6.4% to $6.82 during Wednesday's after-market session. The company's market cap stands at $166.5 million.

AQB

1 minute read

Earnings

Edwards Lifesciences: Q4 Earnings Insights

By Benzinga Insights

Today, 10:52 AM

Edwards Lifesciences (NYSE:EW) reported its Q4 earnings results on Wednesday, January 26, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

Feed Symbols: EW